Top compounds associated with response to TIMELESS


Feature Type Standardized
Nominal ANOVA
mRNA pac-1 CTRPv2 pan-cancer AAC 0.22 5e-09
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-09
mRNA barasertib CTRPv2 pan-cancer AAC 0.19 9e-09
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA manumycin A CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA alisertib CTRPv2 pan-cancer AAC 0.18 4e-08
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.2 4e-08
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA PD318088 CTRPv2 pan-cancer AAC -0.2 4e-08
Download CSV